Supreet Sethi is a Nephrology physician affiliated with University of California, Los Angeles. OpenAlex indexes 33 publications with 879 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 Ucla Medical Plz Ste 565c
Los Angeles, CA 900959000
Telephone
310-267-2555Provider last certified this registry record 1 Nov 2024.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20251 payment
- Alnylam Pharmaceuticals Inc.Program year20251 payment
- Veloxis Pharmaceuticals, Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
47%Calcium channel blocker15.4%Nifedipine Er54%Amlodipine Besylate46%Part D≥32 patientsBeta blocker8.4%Carvedilol70%Metoprolol Tartrate30%Part D<11 patients+ 7 more classes in this area
Metabolism & gastrointestinal
19.8%Corticosteroid7.9%Prednisone100%Part D≥39 patientsH2 blocker4.7%Famotidine100%Part D≥20 patients+ 4 more classes in this area
Anti-infectives
12.3%Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor6.6%Valganciclovir Hcl100%Part D≥24 patientsShort-acting sulfonamides3.7%Sulfamethoxazole-Trimethoprim100%Part D≥17 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregg Fonarow, MD
University of California, Los Angeles
Dennis Slamon, MD
University of California, Los Angeles
Tomas Ganz, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”